Search results for "PEM"
showing 10 items of 623 documents
Directionnalité graphique et dominance manuelle : une perspective développementale et interculturelle
2012
In the present work, we try to provide some understanding about the factors underlying the directional tendencies, by examining the impact of biomechanical constraints and cultural habits on directionality in graphic movements. French and Syrian subjects, children and adults, were compared in six experiments in order, to put in evidence the cognitive and psychomotor differences caused by the fact that the Eastern and Western cultures oppose on the directionality of writing and reading habits, and that the two hands are opposite in the directionality by adopting movements determined by biomechanical constraints. Likewise, this comparison allowed us to determine the relative strength of these…
Les mosaïques
1995
La sculpture
1995
L'abbatiale Saint-étienne de Dijon et ses cryptes
1998
L'église Saint-Vorles de ChÂtillon et les principes de sa construction
1992
International audience
Une cathédrale et ses fidèles : Notre-Dame de Rouen à la fin du Moyen Âge
1997
International audience
Peindre à Auxerre aux IXe-XIVe siècles. 10 ans de recherche à l'abbaye Saint-Germain d'Auxerre et à la cathédrale Saint-étienne d'Auxerre
1999
International audience
Lipidograma y metabolismo óseo, estudio clínico y analítico en la cohorte “CARMEN”
2019
La Organización Mundial de Sanidad (OMS) atribuye a la enfermedad cardiovascular (ECV) la principal causa de muerte en el mundo, con 15 millones de fallecimientos por dicha patología según los últimos datos de 2016. La incidencia de ECV aumenta con la edad como también lo hace la incidencia de osteoporosis, una patología esquelética que representa la principal causa de morbilidad en la población anciana. Ambas patologías tienen un importante incremento a partir de la menopausia, de hecho, en España, el 26% de las mujeres mayores de 50 años presentan osteoporosis. La patogénesis de la ECV y de la osteoporosis ha sido ampliamente estudiada. Así, se ha encontrado que la arteriosclerosis repres…
In the literature: February 2019
2019
Malignant pleural mesothelioma (MPM) is a rare and lethal cancer associated to asbestos exposure. Currently, the pemetrexed and cisplatin combination chemotherapy remains the only approved treatment. In the last 5 years, a growing knowledge on mesothelioma pathobiology has translated into the development of multiple novel therapeutic strategies.1 One of the largest reports of comprehensive genomic profiling of MPM was conducted by Bueno and colleagues. Using RNA-seq data, they identified four distinct molecular subtypes, and through exome analysis, they found that BAP1 , NF2 , TP53 , SETD2 , DDX3X , ULK2 , RYR2 , CFAP45 , SETDB1 and DDX51 were significantly mutated.2 In an article recently …
Lenvatinib (len) plus pembrolizumab (pembro) for the first-line treatment of patients (pts) with advanced hepatocellular carcinoma (HCC): Phase 3 LEA…
2019
TPS4152 Background: Len, an inhibitor of VEGF receptors 1-3, FGF receptors 1-4, PDGF receptor α, RET, and KIT, is approved for first-line treatment of unresectable HCC (uHCC) based on the open-label phase 3 REFLECT study in which len showed noninferior overall survival (OS) and significantly improved objective response rate (ORR), progression-free survival (PFS), and time-to-progression (TTP) vs sorafenib. In the phase 2 KEYNOTE-224 study of pembro (a PD-1 inhibitor) as second-line treatment of advanced HCC, pembro showed meaningful clinical efficacy in pts previously treated with sorafenib, with median PFS 4.9 mo, median OS 12.9 mo, and a manageable safety profile. In results from the pha…